IORT devices market set for steady growth through 2030

The global intraoperative radiotherapy devices market is expected to rise from $0.5 billion in 2026 to $0.7 billion by 2030, driven by cancer growth, more precision-focused treatment, and wider use of image-guided surgery. North America led the market in 2025, while Western Europe is projected to grow fastest over the forecast period.

Why it matters: - Intraoperative radiotherapy devices are gaining traction as cancer centers look for more precise radiation delivery during surgery. - The technology can target the surgical site immediately after tumor removal, which may reduce damage to healthy tissue and limit the need for multiple follow-up radiation sessions. - Breast cancer demand is a major driver because more patients undergoing breast-conserving surgery are seeking targeted treatment options.

What happened: - The Business Research Company published its Intraoperative Radiotherapy (IORT) Devices Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report says the IORT devices market will grow from $0.46 billion in 2025 to $0.5 billion in 2026. - The report projects the market will reach $0.7 billion by 2030. - The forecast implies an 8.4% CAGR from 2025 to 2026 and an 8.6% CAGR through 2030. - The report describes IORT devices as medical tools that deliver concentrated radiation directly to the surgical site after tumor removal. - The report also says the devices combine radiation delivery systems with imaging technologies for use during surgery. - A free sample of the report is available. - The full market report is also available.

The details: - The market’s recent growth is tied to rising cancer incidence, broader adoption of advanced oncology techniques, stronger demand for focused radiation therapies, expanding oncology care infrastructure, and wider clinical acceptance of intraoperative treatment methods. - Future growth is expected to come from more personalized cancer therapies, greater demand for radiation precision, rising use of mobile IORT systems, better integration of image-guided surgical tools, and higher investment in oncology treatment centers. - The report points to precise radiation technologies, real-time imaging during surgery, single-session cancer treatment, minimally invasive oncology solutions, and compact portable radiotherapy devices as key trends. - Breast cancer remains a key use case for the market because IORT can support treatment during breast-conserving surgery. - The report cites Centers for Disease Control and Prevention data showing 288,494 new female breast cancer cases in the United States in 2023 and 43,402 deaths in 2024. - In 2025, North America held the largest share of the IORT devices market. - Western Europe is expected to be the fastest-growing region over the forecast period. - The report also covers Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East, and Africa.

Between the lines: - The market outlook suggests oncology buyers are prioritizing treatment precision over broader radiation exposure. - The emphasis on mobile and portable systems points to demand for tools that can fit into operating-room workflows without major infrastructure changes. - The regional split hints that mature markets are still driving revenue, while Europe may be the next growth pocket.

What's next: - The Business Research Company says its 2026 reports include market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated trend analysis. - The report signals continued investment in image-guided surgery and compact radiotherapy systems as the market expands toward 2030.

The bottom line: - IORT devices are moving from a niche oncology toolset toward a broader growth market, with cancer prevalence and surgical precision shaping the next phase of demand.